Research Article
Burden of Cardiovascular Diseases in Nepal from 1990 to 2019: The Global Burden of Disease Study, 2019
Table 3
Mortality rates (per 100,000 population) and proportion of deaths attributable to different CVDs in 2019.
| | Mortality rates of both sex | % of total deaths in both sex (95% UI) | Mortality rates in male | % of total deaths in male (95% UI) | Mortality rates in female | % of total deaths in female (95% UI) | All-age mortality rates (95% UI) | Age-standardized mortality rate(95% UI) | All-age mortality rates (95% UI) | Age-standardized mortality rates(95% UI) | All-age mortality rates (95% UI) | Age-standardized mortality rates(95% UI) |
| Ischemic heart disease | 78.06 (61.53–94.72) | 123.99 (98.62–148.27) | 12.27 (10.69–14.09) | 109.38 (83.58–134.52) | 173.68 (133.43–213.06) | 15.01 (12.92–17.62) | 49.53 (35.67–64.28) | 80.14 (57.24–104.75) | 8.98 (6.59–11.33) | Stroke | 49.94 (39.33–61.4) | 80.44 (63.44–98.61) | 7.85 (6.72–9.3) | 60.31 (46.13–77.31) | 96.97 (74.69–123.26) | 8.28 (6.97–10.19) | 40.49 (30.35–53.15) | 65.79 (49.13–85.73) | 7.34 (5.72–9.28) | Rheumatic heart disease | 9.23 (5.93–13.86) | 13.36 (8.76–20.49) | 1.45 (0.99–2.13) | 9.76 (5.65–19.51) | 14.41 (8.22–29.43) | 1.34 (0.81–2.6) | 8.75 (5.17–13.84) | 12.43 (7.36–19.34) | 1.59 (0.99–2.43) | Hypertensive heart disease | 8.01 (5.78–11.17) | 14.27 (10.41–20.24) | 1.26 (0.94–1.74) | 7.03 (4.53–10.23) | 12.29 (8.11–17.68) | 0.97 (0.66–1.36) | 8.9 (5.17–14.03) | 15.93 (9.38–25.05) | 1.61 (0.98–2.52) | Other cardiovascular and circulatory diseases | 2.88 (1.98–4.3) | 4.57 (3.14–6.88) | 0.45 (0.34–0.66) | 3.19 (2.04–5.37) | 5.09 (3.26–8.69) | 0.44 (0.31–0.72) | 2.59 (1.81–3.7) | 4.12 (2.87–6.01) | 0.47 (0.34–0.67) | Atrial fibrillation and flutter | 1.87 (1.24–2.49) | 4.08 (2.67–5.52) | 0.29 (0.2–0.39) | 1.84 (1.06–2.72) | 4.13 (2.38–6.15) | 0.25 (0.15–0.37) | 1.9 (1.15–2.71) | 4.04 (2.41–5.77) | 0.34 (0.21–0.49) | Aortic aneurysm | 1.07 (0.68–1.47) | 1.72 (1.1–2.32) | 0.17 (0.11–0.22) | 1.49 (0.87–2.25) | 2.37 (1.37–3.52) | 0.21 (0.13–0.3) | 0.68 (0.45–0.95) | 1.13 (0.75–1.57) | 0.12 (0.08–0.17) | Nonrheumatic valvular heart disease | 0.81 (0.58–1.09) | 1.35 (0.98–1.86) | 0.13 (0.1–0.17) | 0.87 (0.54–1.24) | 1.44 (0.87–2.1) | 0.12 (0.08–0.17) | 0.75 (0.47–1.14) | 1.27 (0.79–1.94) | 0.14 (0.09–0.21) | Cardiomyopathy and myocarditis | 0.44 (0.29–0.65) | 0.67 (0.44–0.97) | 0.07 (0.05–0.1) | 0.61 (0.38–0.91) | 0.92 (0.58–1.39) | 0.08 (0.06–0.12) | 0.28 (0.16–0.51) | 0.44 (0.24–0.79) | 0.05 (0.03–0.09) | Endocarditis | 0.42 (0.31–0.56) | 0.62 (0.45–0.82) | 0.07 (0.05–0.08) | 0.5 (0.32–0.71) | 0.73 (0.46–1.03) | 0.07 (0.05–0.09) | 0.35 (0.22–0.52) | 0.53 (0.33–0.79) | 0.06 (0.04–0.09) | Peripheral artery disease | 0.16 (0.1–0.22) | 0.31 (0.19–0.43) | 0.03 (0.02–0.03) | 0.22 (0.11–0.33) | 0.41 (0.21–0.63) | 0.03 (0.02–0.04) | 0.11 (0.06–0.18) | 0.22 (0.12–0.35) | 0.02 (0.01–0.03) |
|
|